Richard Knox

Since he joined NPR in 2000, Knox has covered a broad range of issues and events in public health, medicine, and science. His reports can be heard on NPR's Morning Edition, All Things Considered, Weekend Edition, Talk of the Nation, and newscasts.

Among other things, Knox's NPR reports have examined the impact of HIV/AIDS in Africa, North America, and the Caribbean; anthrax terrorism; smallpox and other bioterrorism preparedness issues; the rising cost of medical care; early detection of lung cancer; community caregiving; music and the brain; and the SARS epidemic.

Before joining NPR, Knox covered medicine and health for The Boston Globe. His award-winning 1995 articles on medical errors are considered landmarks in the national movement to prevent medical mistakes. Knox is a graduate of the University of Illinois and Columbia University. He has held yearlong fellowships at Stanford and Harvard Universities, and is the author of a 1993 book on Germany's health care system.

He and his wife Jean, an editor, live in Boston. They have two daughters.

Mike Quaglia was 42 when he was diagnosed with Parkinson's disease, which gradually robs its victims of their ability to move normally. For the next seven years, his condition deteriorated despite medication.

"I was at a point where I was either going to give up and let the Parkinson's take over, or I was going to decide to fight back," Quaglia says.

Fight back he did — literally. Last February he stumbled on a program called Rock Steady Boxing. That's right: It teaches Parkinson's patients how to box.

Haiti's magnitude 7.0 earthquake of Jan. 12, 2010, left 220,000 people dead, 300,000 injured and rubble nearly everywhere.

The catastrophe also unleashed an unprecedented flood of humanitarian aid — $13.5 billion in donations and pledges, about three-quarters from donor nations and a quarter from private charity.

But today Haiti is a long, long way from realizing the bullish goal of "building back better."

Authors of the first-ever global guidelines for treating hepatitis C went big Tuesday, advocating for worldwide use of two of the most expensive specialty drugs in the world.

The new guidelines from the World Health Organization give strong endorsement to the two newest drugs. Gilead Sciences' Sovaldi costs $1,000 per pill, or $84,000 for a 12-week course of treatment. Olysio, sold by Johnson & Johnson's Janssen Pharmaceuticals unit, costs $66,360 for a three-month course.

When sweeping new advice on preventing heart attacks and strokes came out last November, it wasn't clear how many more Americans should be taking daily statin pills to lower their risk.

A new analysis provides an answer: a whole lot. Nearly 13 million more, to be precise.

Colorado opened its first pot stores in January, and adults in Washington state will be able to walk into a store and buy marijuana this summer. But this legalization of recreational marijuana is taking place without much information on the possible health effects.